Literature DB >> 15155831

Mutations of charged amino acids in or near the transmembrane helices of the second membrane spanning domain differentially affect the substrate specificity and transport activity of the multidrug resistance protein MRP1 (ABCC1).

Anass Haimeur1, Gwenaëlle Conseil, Roger G Deeley, Susan P C Cole.   

Abstract

Multidrug resistance protein 1 (MRP1) belongs to the ATP-binding cassette superfamily of transport proteins. In addition to drugs, MRP1 mediates the active transport of many conjugated and unconjugated organic anions. MRP1 consists of two membrane-spanning domains (MSD2 and MSD3) each followed by a nucleotide binding domain plus a third NH2-terminal MSD1. MSD2 contains transmembrane (TM) helices 6 through 11, and previously, we identified two charged residues in TM6 as having important but markedly different roles in MRP1 transport activity and substrate specificity by characterizing mutants containing nonconservative substitutions of Lys332 and Asp336. We have now extended these studies and found that the same-charge TM6 mutant K332R, like the nonconservatively substituted Lys332 mutants, exhibits a selective decrease in leukotriene C4 (LTC4) transport, associated with substantial changes in both Km and Vmax and LTC4 binding. The overall organic anion transport activity of the same-charge mutant of Asp336 (D336E) also remained very low, as observed for D336R. In addition, nonconservative substitutions of TM6-associated Lys319 and Lys347 resulted in a selective decrease in GSH transport. Of eight other charged residues in or proximal to TM7 to TM11 that were investigated, nonconservative substitutions of three of them [Lys396 (TM7), Asp436 (TM8), and Arg593 (TM11)] caused a substantial and global reduction in transport activity. However, unlike TM6 Asp336, wild-type transport activity could be reestablished in these MRP1 mutants by conservative substitutions. We conclude that MSD2-charged residues in or proximal to TM6, TM7, TM8, and TM11 play critical but differential roles in MRP1 transport activity and substrate specificity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155831     DOI: 10.1124/mol.65.6.1375

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  14 in total

Review 1.  Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy.

Authors:  Ana Carolina Rabello de Moraes; Caroline Klein Maranho; Gabriela Schneider Rauber; Maria Cláudia Santos-Silva
Journal:  J Clin Lab Anal       Date:  2013-01-04       Impact factor: 2.352

Review 2.  Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases.

Authors:  Zhe-Sheng Chen; Amit K Tiwari
Journal:  FEBS J       Date:  2011-08-01       Impact factor: 5.542

3.  Expression and function of human MRP1 (ABCC1) is dependent on amino acids in cytoplasmic loop 5 and its interface with nucleotide binding domain 2.

Authors:  Surtaj H Iram; Susan P C Cole
Journal:  J Biol Chem       Date:  2010-12-20       Impact factor: 5.157

4.  Functional analysis of nonsynonymous single nucleotide polymorphisms of multidrug resistance-associated protein 2 (ABCC2).

Authors:  Vandana Megaraj; Tianyong Zhao; Christian M Paumi; Phillip M Gerk; Richard B Kim; Mary Vore
Journal:  Pharmacogenet Genomics       Date:  2011-08       Impact factor: 2.089

5.  Arginine 383 is a crucial residue in ABCG2 biogenesis.

Authors:  Orsolya Polgar; Lilangi S Ediriwickrema; Robert W Robey; Ajay Sharma; Ramanujan S Hegde; Yongfu Li; Di Xia; Yvona Ward; Michael Dean; Csilla Ozvegy-Laczka; Balazs Sarkadi; Susan E Bates
Journal:  Biochim Biophys Acta       Date:  2009-05-03

6.  Gln-222 in transmembrane domain 4 and Gln-526 in transmembrane domain 9 are critical for substrate recognition in the yeast high affinity glutathione transporter, Hgt1p.

Authors:  Jaspreet Kaur; Anand K Bachhawat
Journal:  J Biol Chem       Date:  2009-07-09       Impact factor: 5.157

7.  Harnessing drug resistance: using ABC transporter proteins to target cancer cells.

Authors:  Heather M Leitner; Remy Kachadourian; Brian J Day
Journal:  Biochem Pharmacol       Date:  2007-05-21       Impact factor: 5.858

8.  Block of CFTR-dependent chloride currents by inhibitors of multidrug resistance-associated proteins.

Authors:  Tullia Diena; Raffaella Melani; Emanuela Caci; Nicoletta Pedemonte; Elvira Sondo; Olga Zegarra-Moran; Luis J V Galietta
Journal:  Eur J Pharmacol       Date:  2007-02-03       Impact factor: 4.432

9.  Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.

Authors:  Maria Isabel Veiga; Pedro Eduardo Ferreira; Louise Jörnhagen; Maja Malmberg; Aminatou Kone; Berit Aydin Schmidt; Max Petzold; Anders Björkman; Francois Nosten; Jose Pedro Gil
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

10.  Localization of putative binding sites for cyclic guanosine monophosphate and the anti-cancer drug 5-fluoro-2'-deoxyuridine-5'-monophosphate on ABCC11 in silico models.

Authors:  Mylène Honorat; Raphaël Terreux; Pierre Falson; Attilio Di Pietro; Charles Dumontet; Lea Payen
Journal:  BMC Struct Biol       Date:  2013-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.